Fragile sites-cytogenetic similarity with molecular diversity.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 1377744)

Published in Am J Hum Genet on February 01, 1999

Authors

G R Sutherland1, R I Richards

Author Affiliations

1: Department of Cytogenetics and Molecular Genetics, Women's and Children's Hospital, Adelaide 5006, Australia. gsutherland@medicine. adelaide.edu.au

Articles cited by this

Complex gene conversion events in germline mutation at human minisatellites. Nat Genet (1994) 5.70

Expansion and length-dependent fragility of CTG repeats in yeast. Science (1998) 3.25

Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38

Simple repeat DNA is not replicated simply. Nat Genet (1994) 2.37

Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A (1997) 2.36

Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J (1998) 2.23

Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A (1998) 2.16

A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell (1998) 2.00

Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet (1997) 1.74

Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum Mol Genet (1998) 1.65

Precursor arrays for triplet repeat expansion at the fragile X locus. Hum Mol Genet (1994) 1.59

Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55

Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (1994) 1.51

Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett (1998) 1.47

Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet (1998) 1.46

Biological implications of the DNA structures associated with disease-causing triplet repeats. Am J Hum Genet (1999) 1.41

Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature (1995) 1.38

A variable domain of delayed replication in FRAXA fragile X chromosomes: X inactivation-like spread of late replication. Proc Natl Acad Sci U S A (1997) 1.32

CTG repeats show bimodal amplification in E. coli. Cell (1998) 1.24

Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc Natl Acad Sci U S A (1997) 1.24

Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet (1991) 1.23

FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol Cell (1998) 1.20

Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1. Hum Mol Genet (1998) 1.18

Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. Am J Hum Genet (1997) 1.13

Examination of factors associated with instability of the FMR1 CGG repeat. Am J Hum Genet (1998) 1.11

The most common fragile site in man is 3p14. Hum Genet (1986) 1.09

Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer (1998) 1.05

The fragile site (16) (q22). I. Induction by AT-specific DNA-ligands and population frequency. Hum Genet (1986) 0.99

Protein expression and functional analysis of the FHIT gene in human tumor cells. J Natl Cancer Inst (1998) 0.98

Molecular basis of p(CCG)n repeat instability at the FRA16A fragile site locus. Hum Mol Genet (1995) 0.85

Direct cloning and analysis of DNA sequences from a region of the Chinese hamster genome associated with aphidicolin-sensitive fragility. J Cell Sci (1998) 0.83

A tandem array of minimal U1 small nuclear RNA genes is sufficient to generate a new adenovirus type 12-inducible chromosome fragile site. J Virol (1998) 0.80

Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells. Br J Cancer (1998) 0.80

Articles by these authors

(truncated to the top 100)

Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (1984) 7.57

Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene. Nature (1982) 7.05

Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99

Molecular cloning and sequence analysis of adult chicken betal globin cDNA. Nucleic Acids Res (1979) 4.49

Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18

Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. Cell (1984) 3.08

Primary structure and evolution of rat growth hormone gene. Proc Natl Acad Sci U S A (1981) 2.80

Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet (2000) 2.56

Simple repeat DNA is not replicated simply. Nat Genet (1994) 2.37

Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature (1983) 2.25

Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A (1995) 2.18

Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. Genomics (1992) 2.00

Fragile sites still breaking. Trends Genet (1998) 1.86

Molecular cloning of the mouse angiotensinogen gene. Genomics (1988) 1.75

Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus. J Biol Chem (1987) 1.60

Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55

Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (1994) 1.51

Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet (1992) 1.47

Human metallothionein genes: molecular cloning and sequence analysis of the mRNA. Nucleic Acids Res (1982) 1.47

Human metallothionein genes: structure of the functional locus at 16q13. Genomics (1990) 1.46

Dinucleotide repeat polymorphisms at the D16S164, D16S168 and D16S186 loci at 16q21-q22.1. Nucleic Acids Res (1991) 1.42

Fragile X syndrome: the most common cause of familial mental retardation. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1994) 1.39

Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature (1995) 1.38

Structure and tissue-specific expression of the human metallothionein IB gene. Mol Cell Biol (1986) 1.35

The molecular basis of fragile sites in human chromosomes. Curr Opin Genet Dev (1995) 1.32

Chicken globin genes. Nucleotide sequence of cDNA clones coding for the alpha-globin expressed during hemolytic anemia. J Biol Chem (1980) 1.28

Hereditary unstable DNA: a new explanation for some old genetic questions? Lancet (1991) 1.28

Mouse glandular kallikrein genes. Identification, structure, and expression of the renal kallikrein gene. J Biol Chem (1986) 1.27

Familial Mediterranean fever (FMF) in Moroccan Jews: demonstration of a founder effect by extended haplotype analysis. Am J Hum Genet (1993) 1.25

Kallikreins, kinins and growth factor biosynthesis. Trends Biochem Sci (1988) 1.23

FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol Cell (1998) 1.20

Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res (2000) 1.17

Fine genetic mapping of the Batten disease locus (CLN3) by haplotype analysis and demonstration of allelic association with chromosome 16p microsatellite loci. Genomics (1993) 1.16

Refined mapping of the gene causing familial Mediterranean fever, by linkage and homozygosity studies. Am J Hum Genet (1993) 1.16

Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J (1986) 1.15

Heritable unstable DNA sequences. Nat Genet (1992) 1.13

Four dinucleotide repeat polymorphisms on human chromosome 16 at D16S289, D16S318, D16S319 and D16S320. Hum Mol Genet (1992) 1.12

Dinucleotide repeat polymorphism at D16S287. Nucleic Acids Res (1991) 1.11

Predictive diagnosis of myotonic dystrophy with flanking microsatellite markers. J Med Genet (1991) 1.10

Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet (1994) 1.07

Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangement in AMMoL. Science (1987) 1.07

Human prostate specific antigen (PSA) gene: structure and linkage to the kallikrein-like gene, hGK-1. Nucleic Acids Res (1989) 1.03

Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet (1992) 1.02

A 5' flanking region of the metallothionein, MT2A, gene identifies two moderately frequent RFLPs. Nucleic Acids Res (1987) 1.00

Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus. Neurology (2004) 0.99

Genes for the alpha and gamma subunits of mouse nerve growth factor are contiguous. EMBO J (1985) 0.98

Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246. Am J Hum Genet (1996) 0.97

Experience with direct molecular diagnosis of fragile X. J Med Genet (1992) 0.95

The human metallothionein gene family: structure and expression. Environ Health Perspect (1984) 0.94

DNA repeats--a treasury of human variation. N Engl J Med (1994) 0.94

A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum. J Mol Med (Berl) (2001) 0.93

Dynamic mutations on the move. J Med Genet (1993) 0.93

A linkage map of microsatellite markers on the human X chromosome. Genomics (1994) 0.92

Anticipation legitimized: unstable DNA to the rescue. Am J Hum Genet (1992) 0.91

Analysis of replication timing at the FRA10B and FRA16B fragile site loci. Chromosome Res (2000) 0.91

Chromosomal localization of the human P2y6 purinoceptor gene and phylogenetic analysis of the P2y purinoceptor family. Genomics (1997) 0.91

Mouse glandular kallikrein genes. Nucleotide sequence of cloned cDNA coding for a member of the kallikrein arginyl esteropeptidase group of serine proteases. J Biol Chem (1982) 0.90

Localisation of a 10q breakpoint within the PAX2 gene in a patient with a de novo t(10;13) translocation and optic nerve coloboma-renal disease. J Med Genet (1997) 0.90

Alpha-inhibin gene expression occurs in the ovine adrenal cortex, and is regulated by adrenocorticotropin. Mol Endocrinol (1987) 0.89

Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res (1997) 0.88

Sixth international workshop on the fragile X and X-linked mental retardation. Am J Med Genet (1994) 0.87

Molecular basis of p(CCG)n repeat instability at the FRA16A fragile site locus. Hum Mol Genet (1995) 0.85

Expression and hormonal regulation of the rat growth hormone gene in transfected mouse L cells. DNA (1984) 0.85

Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice. EMBO J (1989) 0.84

Unbalanced t(4;11)(q32;q23) in a 34-year-old man with manifestations of distal monosomy 11q and trisomy 4q syndromes. Am J Med Genet (1997) 0.83

Characterization of new PCR based markers for mapping and diagnosis: AC dinucleotide repeat markers at the DXS237 (GMGX9) and DXS102 (cX38.1) loci. Am J Med Genet (1992) 0.83

Cellular basis for the differential response of mouse kallikrein genes to hormonal induction. EMBO J (1987) 0.83

Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13. Cytogenet Cell Genet (1988) 0.82

Dinucleotide repeat polymorphisms at the DXS294 and DXS300 loci in Xq26. Nucleic Acids Res (1991) 0.82

Dinucleotide repeat polymorphisms at the D16S525, D16S359, D16S531 and D16S522 loci. Hum Mol Genet (1994) 0.82

Mouse glandular kallikrein genes: identification and characterization of the genes encoding the epidermal growth factor binding proteins. Biochemistry (1987) 0.82

Fragile sites and minisatellite repeat instability. Mol Genet Metab (2000) 0.82

CAG repeat expansion in autosomal dominant familial spastic paraparesis: novel expansion in a subset of patients. Hum Mol Genet (1998) 0.80

The kallikrein multigene family: specific processing of biologically active peptides. Cold Spring Harb Symp Quant Biol (1983) 0.80

The angiotensinogen gene is located on mouse chromosome 8. FEBS Lett (1989) 0.80

Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3. Genomics (1997) 0.80

Construction of an approximately 700-kb transcript map around the familial Mediterranean fever locus on human chromosome 16p13.3. Genome Res (1998) 0.80

Isolation and characterization of transcribed sequences from a chromosome 16 hn-cDNA library and the physical mapping of genes and transcribed sequences using a high-resolution somatic cell panel of human chromosome 16. Genomics (1994) 0.79

Mouse kallikrein arginyl-esteropeptidase genes: analysis of cloned cDNAs suggests rapid functional divergence from a common ancestral sequence. DNA (1982) 0.79

Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum Genet (1999) 0.79

The function of conserved elements in the promoter of the mouse angiotensinogen gene. J Mol Endocrinol (1992) 0.78

Four dinucleotide repeat polymorphisms on human chromosome 16. Hum Mol Genet (1993) 0.78

Dinucleotide repeat polymorphism at the D16S288 locus. Nucleic Acids Res (1991) 0.78

An allelic polymorphism of the angiotensinogen gene in mice. Nucleic Acids Res (1989) 0.77

FRAXAC2 instability. Nat Genet (1994) 0.77

Differential binding of thyroid hormone receptors to mouse glandular kallikrein gene promoters: evidence for multiple binding regions in the mGK-6 gene. J Mol Endocrinol (1989) 0.77

Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. Am J Hum Genet (1997) 0.77

Modeling and analysis of repeat RNA toxicity in Drosophila. Methods Mol Biol (2013) 0.76

Sequence and expression of mouse gamma-renin. J Biol Chem (1988) 0.76

An STS at the D16S290 locus. Nucleic Acids Res (1991) 0.75

A strategy for assigning end-fragments of genomic DNA cloned into the cosmid vector pJB8. Nucleic Acids Res (1987) 0.75

Sequence of mGK-11, a mouse glandular kallikrein gene. Nucleic Acids Res (1988) 0.75

Sequence of the mouse glandular kallikrein gene, mGK-5. Nucleic Acids Res (1987) 0.75

Informative microsatellite markers allow carrier detection in a Duchenne muscular dystrophy deletion pedigree in the absence of DNA from an affected boy. Am J Hum Genet (1992) 0.75

Fragile X syndrome. The most common cause of familial intellectual handicap. Med J Aust (1993) 0.75

Three dinucleotide repeat polymorphisms on human chromosome 16p13.11-p13.3. Hum Mol Genet (1993) 0.75

Unusual inheritance patterns due to dynamic mutation in fragile X syndrome. Ciba Found Symp (1996) 0.75

Prenatal diagnosis and successful intrauterine treatment of a female fetus with 21-hydroxylase deficiency. Med J Aust (1992) 0.75

Thyroid hormone receptors from IM-9 cells but not HeLa cells bind to promoters of triiodothyronine-responsive genes. Mol Cell Endocrinol (1990) 0.75

Inducible anti-sense RNA for angiotensinogen in stably transformed hepatoma cell lines. J Mol Endocrinol (1990) 0.75